The UK government has introduced a Modern Industrial Strategy focusing on boosting the life sciences sector to rank as Europe’s leader by 2030 and among the top three globally by 2035. Key investments include nearly £900 million for Genomics England, health data programs like Our Future Health, and enhancements to clinical trial infrastructure. The strategy aims to streamline trial approval processes, develop an AI-ready secure health data platform, and transform the Medicines and Healthcare products Regulatory Agency into a faster regulator excelling in market access. This comprehensive, long-term plan reflects efforts to reduce regulatory burdens and foster growth in high-potential sectors.